Patients who will be receiving cyclosporine, tacrolimus or other agents to prevent graft-vs .-host condition article bone marrow transplant aren't suitable for this trial Experimental: Dose expansion_sub-inhabitants 2_lower dose of niraparib MTDs and/or prospect RP2Ds for elimusertib employed in combination with niraparib in a reduced fastened dose. testing, sample dimension https://thomasf344sdn6.howeweb.com/profile